Literature DB >> 28682499

High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia.

Q Feng1, M Xu1,2, Y Y Yu1, Y Hou1, X Mi1, Y X Sun1, S Ma1, X Y Zuo1, L L Shao1, M Hou1,3, X H Zhang4, J Peng1.   

Abstract

Essentials M1/M2 imbalance is involved in many autoimmune diseases, and could be restored. The expressions and functions of M1 and M2 were investigated in an in vitro culture system. A preferred M1 polarization is involved in the pathogenesis of immune thrombocytopenia (ITP). High-dose dexamethasone or all-trans-retinoic acid restores M1/M2 balance in ITP patients.
SUMMARY: Background Immune thrombocytopenia (ITP) is an autoimmune disorder. Deficiency of immune tolerance in antigen-presenting cells and cross-communication between antigen-presenting cells and T cells are involved in the pathogenesis of ITP. Macrophages can polarize into proinflammatory M1 or anti-inflammatory M2 phenotypes in response to different environmental stimuli, and have diverse immunologic functions. Objectives To investigate the M1/M2 imbalance in ITP and whether high-dose dexamethasone (HD-DXM) or all-trans-retinoic acid (ATRA) could restore this imbalance. Methods The numbers of M1 and M2 macrophages in the spleens of ITP patients and patients with traumatic spleen rupture were analyzed by immunofluorescence. Monocyte-derived macrophages were cultured and induced with cytokines and drugs. The expression of M1 and M2 markers and functions of M1 and M2 macrophages before and after modulation by HD-DXM or ATRA were evaluated with flow cytometry and ELISA. Results There was preferred M1 polarization in ITP spleens as compared with healthy controls. Monocyte-derived macrophages from ITP patients had increased expression of M1 markers and impaired immunosuppressive functions. Either HD-DXM or ATRA corrected this imbalance by decreasing the expression of M1 markers and increasing the expression of M2 markers. Moreover, HD-DXM-modulated or ATRA-modulated macrophages suppressed both CD4+ and CD8+ T-cell proliferation and expanded CD4+ CD49+ LAG3+ type 1 T-regulatory cells. HD-DXM or ATRA modulated macrophages to shift the T-cell cytokine profile towards Th2. Treating patients with HD-DXM or ATRA revealed that macrophages induced from responders showed a predominant M2-like phenotype and immunosuppressive function. Conclusions Aberrant macrophage polarization is involved in the pathogenesis of ITP. Either HD-DXM or ATRA is able to correct this imbalance.
© 2017 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  all-trans-retinoic acid; dexamethasone; immune thrombocytopenia; immunomodulation; macrophage

Mesh:

Substances:

Year:  2017        PMID: 28682499     DOI: 10.1111/jth.13767

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  16 in total

Review 1.  The role of β-carotene and vitamin A in atherogenesis: Evidences from preclinical and clinical studies.

Authors:  Anthony P Miller; Johana Coronel; Jaume Amengual
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-21       Impact factor: 4.698

2.  SIRT1 single-nucleotide polymorphisms are associated with corticosteroid sensitivity in primary immune thrombocytopenia patients.

Authors:  Shuwen Wang; Xiaoyu Zhang; Shaoqiu Leng; Yanqi Zhang; Ju Li; Jun Peng; Zeping Zhou; Qi Feng; Xiang Hu
Journal:  Ann Hematol       Date:  2021-07-16       Impact factor: 3.673

3.  Distinct alterations of CD68+CD163+ M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment.

Authors:  Xia Shao; Boting Wu; Luya Cheng; Feng Li; Yanxia Zhan; Chanjuan Liu; Lili Ji; Zhihui Min; Yang Ke; Lihua Sun; Hao Chen; Yunfeng Cheng
Journal:  J Transl Med       Date:  2018-03-02       Impact factor: 5.531

Review 4.  Phytochemicals as modulators of M1-M2 macrophages in inflammation.

Authors:  Uzma Saqib; Sutripta Sarkar; Kyoungho Suk; Owais Mohammad; Mirza S Baig; Rajkumar Savai
Journal:  Oncotarget       Date:  2018-04-03

5.  Autoinflammatory characteristics and short-term effects of delivering high-dose steroids to the surface of the intact endolymphatic sac and incus in refractory Ménière's disease.

Authors:  Jing Zou
Journal:  J Otol       Date:  2019-01-06

6.  All-trans retinoic acid protects mesenchymal stem cells from immune thrombocytopenia by regulating the complement-interleukin-1β loop.

Authors:  Xiaolu Zhu; Yanan Wang; Qian Jiang; Hao Jiang; Jin Lu; Yazhe Wang; Yuan Kong; Yingjun Chang; Lanping Xu; Jun Peng; Ming Hou; Xiaojun Huang; Xiaohui Zhang
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

7.  miRNA-98-5p Targeting IGF2BP1 Induces Mesenchymal Stem Cell Apoptosis by Modulating PI3K/Akt and p53 in Immune Thrombocytopenia.

Authors:  Yanan Wang; Jiamin Zhang; Yan Su; Chencong Wang; Gaochao Zhang; Xiao Liu; Qi Chen; Meng Lv; Yingjun Chang; Jun Peng; Ming Hou; Xiaojun Huang; Xiaohui Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-01       Impact factor: 8.886

Review 8.  Heterogeneous macrophages: Supersensors of exogenous inducing factors.

Authors:  Caiyun Qian; Zehui Yun; Yudi Yao; Minghua Cao; Qiang Liu; Song Hu; Shuhua Zhang; Daya Luo
Journal:  Scand J Immunol       Date:  2019-05-09       Impact factor: 3.487

9.  Intestinal Macrophages Balance Inflammatory Expression Profiles via Vitamin A and Dectin-1-Mediated Signaling.

Authors:  Martje N Erkelens; Gera Goverse; Tanja Konijn; Rosalie Molenaar; Marieke R Beijer; Jan Van den Bossche; Kyra E de Goede; Sanne G S Verberk; Wouter J de Jonge; Joke M M den Haan; Reina E Mebius
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

10.  The anti-B7-H4 checkpoint synergizes trastuzumab treatment to promote phagocytosis and eradicate breast cancer.

Authors:  Xiaochen Hu; Yiwen Liu; Xiusen Zhang; Dejiu Kong; Jinyu Kong; Di Zhao; Yibo Guo; Lingyun Sun; Luoyi Chu; Shupei Liu; Xurong Hou; Feng Ren; Ying Zhao; Chengbiao Lu; Desheng Zhai; Xiang Yuan
Journal:  Neoplasia       Date:  2020-09-20       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.